Literature DB >> 20016957

Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes.

.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20016957     DOI： 10.1007/s12015-009-9085-x

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN： 2629-3277            Impact factor:   5.739


× No keyword cloud information.
  16 in total

1.  Detection of mycoplasma contaminations.

Authors:  Cord C Uphoff; Hans G Drexler
Journal:  Methods Mol Biol       Date:  2005

2.  Development of a PCR method for mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins.

Authors:  Joyce A Eldering; Chantal Felten; Connie A Veilleux; Barbara J Potts
Journal:  Biologicals       Date:  2004-12       Impact factor: 1.856

3.  Cell biology. Cases of mistaken identity.

Authors:  Rhitu Chatterjee
Journal:  Science       Date:  2007-02-16       Impact factor: 47.728

4.  Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR.

Authors:  F J van Kuppeveld; K E Johansson; J M Galama; J Kissing; G Bölske; J T van der Logt; W J Melchers
Journal:  Appl Environ Microbiol       Date:  1994-01       Impact factor: 4.792

Review 5.  The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on.

Authors:  Jeremy Micah Crook; Derek Hei; Glyn Stacey
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-03       Impact factor: 2.416

6.  Probability tables for exclusion of mosaicism in prenatal diagnosis.

Authors:  B Sikkema-Raddatz; S Castedo; G J Te Meerman
Journal:  Prenat Diagn       Date:  1997-02       Impact factor: 3.050

7.  Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use.

Authors:  E B Hook
Journal:  Am J Hum Genet       Date:  1977-01       Impact factor: 11.025

8.  Detection of multiple mycoplasma infection in cell cultures by PCR.

Authors:  J Timenetsky; L M Santos; M Buzinhani; E Mettifogo
Journal:  Braz J Med Biol Res       Date:  2006-07       Impact factor: 2.590

Review 9.  Subversion and exploitation of host cells by mycoplasmas.

Authors:  S Rottem; Y Naot
Journal:  Trends Microbiol       Date:  1998-11       Impact factor: 17.079

10.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.

Authors:  Oluseun Adewumi; Behrouz Aflatoonian; Lars Ahrlund-Richter; Michal Amit; Peter W Andrews; Gemma Beighton; Paul A Bello; Nissim Benvenisty; Lorraine S Berry; Simon Bevan; Barak Blum; Justin Brooking; Kevin G Chen; Andre B H Choo; Gary A Churchill; Marie Corbel; Ivan Damjanov; Jon S Draper; Petr Dvorak; Katarina Emanuelsson; Roland A Fleck; Angela Ford; Karin Gertow; Marina Gertsenstein; Paul J Gokhale; Rebecca S Hamilton; Ales Hampl; Lyn E Healy; Outi Hovatta; Johan Hyllner; Marta P Imreh; Joseph Itskovitz-Eldor; Jamie Jackson; Jacqueline L Johnson; Mark Jones; Kehkooi Kee; Benjamin L King; Barbara B Knowles; Majlinda Lako; Franck Lebrin; Barbara S Mallon; Daisy Manning; Yoav Mayshar; Ronald D G McKay; Anna E Michalska; Milla Mikkola; Masha Mileikovsky; Stephen L Minger; Harry D Moore; Christine L Mummery; Andras Nagy; Norio Nakatsuji; Carmel M O'Brien; Steve K W Oh; Cia Olsson; Timo Otonkoski; Kye-Yoon Park; Robert Passier; Hema Patel; Minal Patel; Roger Pedersen; Martin F Pera; Marian S Piekarczyk; Renee A Reijo Pera; Benjamin E Reubinoff; Allan J Robins; Janet Rossant; Peter Rugg-Gunn; Thomas C Schulz; Henrik Semb; Eric S Sherrer; Henrike Siemen; Glyn N Stacey; Miodrag Stojkovic; Hirofumi Suemori; Jin Szatkiewicz; Tikva Turetsky; Timo Tuuri; Steineke van den Brink; Kristina Vintersten; Sanna Vuoristo; Dorien Ward; Thomas A Weaver; Lesley A Young; Weidong Zhang
Journal:  Nat Biotechnol       Date:  2007-06-17       Impact factor: 54.908
View more
  40 in total

1.  Stem cell banking: between traceability and identifiability.

Authors:  Bartha M Knoppers; Rosario Isasi
Journal:  Genome Med       Date:  2010-10-05       Impact factor: 11.117

2.  Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.

Authors:  Veronica Ramos-Mejia; Gustavo J Melen; Laura Sanchez; Ivan Gutierrez-Aranda; Gertrudis Ligero; Jose L Cortes; Pedro J Real; Clara Bueno; Pablo Menendez
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

3.  The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.

Authors:  David A Brindley; Anna French; Jane Suh; MacKenna Roberts; Benjamin Davies; Rafael Pinedo-Villanueva; Karolina Wartolowska; Kelly Rooke; Anneke Kramm; Andrew Judge; Mark Morrey; Amit Chandra; Hannah Hurley; Liam Grover; Ian Bingham; Bernard Siegel; Matt S Rattley; R Lee Buckler; David McKeon; Katie Krumholz; Lilian Hook; Michael May; Sarah Rikabi; Rosie Pigott; Megan Morys; Afsie Sabokbar; Emily Titus; Yacine Laabi; Gilles Lemaitre; Raymond Zahkia; Doug Sipp; Robert Horne; Christopher Bravery; David Williams; Ivan Wall; Evan Y Snyder; Jeffrey M Karp; Richard W Barker; Kim Bure; Andrew J Carr; Brock Reeve
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

4.  The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice.

Authors:  Alison Murdoch; Peter Braude; Aidan Courtney; Daniel Brison; Charles Hunt; James Lawford-Davies; Harry Moore; Glyn Stacey; Sebastian Sethe
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 5.  Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.

Authors:  Chad Tang; Micha Drukker
Journal:  Semin Immunopathol       Date:  2011-04-11       Impact factor: 9.623

Review 6.  Infectious problems associated with transplantation of cells differentiated from pluripotent stem cells.

Authors:  Outi Hovatta
Journal:  Semin Immunopathol       Date:  2011-04-09       Impact factor: 9.623

Review 7.  The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on.

Authors:  Jeremy Micah Crook; Derek Hei; Glyn Stacey
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-03       Impact factor: 2.416

Review 8.  Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Authors:  Joanna S T Asprer; Uma Lakshmipathy
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

9.  The Wistar legacy to embryonic stem cell research.

Authors:  Barbara B Knowles
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06-03

10.  Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.

Authors:  Ivan Gutierrez-Aranda; Veronica Ramos-Mejia; Clara Bueno; Martin Munoz-Lopez; Pedro J Real; Angela Mácia; Laura Sanchez; Gertrudis Ligero; Jose L Garcia-Parez; Pablo Menendez
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.